Reata Pharmaceuticals
(NASDAQ:RETA)
$35.70
At close: Aug 5
$35.70
PreMarket: 4:01PM EDT
Day High/Low- - -
52 Week High/Low20.24 - 40.64
Open / Close- / -
Float / Outstanding20.3M / 36.5M
Vol / Avg.0.6K / 410.7K
Mkt Cap1.3B
P/E-
50d Avg. Price32.36
Div / Yield-
Payout Ratio-
EPS-2.03
Total Float20.3M

Reata Pharmaceuticals (NASDAQ:RETA), Quotes and News Summary

Reata Pharmaceuticals (NASDAQ: RETA)

Day High/Low- - -
52 Week High/Low20.24 - 40.64
Open / Close- / -
Float / Outstanding20.3M / 36.5M
Vol / Avg.0.6K / 410.7K
Mkt Cap1.3B
P/E-
50d Avg. Price32.36
Div / Yield-
Payout Ratio-
EPS-2.03
Total Float20.3M
Sector: Health Care.Industry: Pharmaceuticals
Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-07
REV
Q2 2022Est.ActualSurprise
EPS-2.020

(EXPECTED) 2022-08-08

REV1.460M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Reata Pharmaceuticals Questions & Answers

Q
How do I buy Reata Pharmaceuticals (RETA) stock?
A

You can purchase shares of Reata Pharmaceuticals (NASDAQ: RETA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Reata Pharmaceuticals's (RETA) competitors?
Q
What is the target price for Reata Pharmaceuticals (RETA) stock?
A

The latest price target for Reata Pharmaceuticals (NASDAQ: RETA) was reported by Citigroup on Friday, May 27, 2022. The analyst firm set a price target for 46.00 expecting RETA to rise to within 12 months (a possible 28.85% upside). 9 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Reata Pharmaceuticals (RETA)?
A

The stock price for Reata Pharmaceuticals (NASDAQ: RETA) is $35.7 last updated August 5, 2022, 8:00 PM UTC.

Q
Does Reata Pharmaceuticals (RETA) pay a dividend?
A

There are no upcoming dividends for Reata Pharmaceuticals.

Q
When is Reata Pharmaceuticals (NASDAQ:RETA) reporting earnings?
A

Reata Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 7, 2022.

Q
Is Reata Pharmaceuticals (RETA) going to split?
A

There is no upcoming split for Reata Pharmaceuticals.

Q
What sector and industry does Reata Pharmaceuticals (RETA) operate in?
A

Reata Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.